Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or a Combination of Pembrolizumab + Axitinib or Avelumab + Axitinib in First Line Therapy

Name: Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or a Combination of Pembrolizumab + Axitinib or Avelumab + Axitinib in First Line Therapy
License: Public Domain

AIO-Studien-gGmbH

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

renal cell carcinoma, metastatic, renal cell cancer, recurrent

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 429671
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.